Mark A. Preston

6.0k total citations · 1 hit paper
123 papers, 2.7k citations indexed

About

Mark A. Preston is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Mark A. Preston has authored 123 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Surgery, 49 papers in Pulmonary and Respiratory Medicine and 25 papers in Oncology. Recurrent topics in Mark A. Preston's work include Bladder and Urothelial Cancer Treatments (60 papers), Urinary and Genital Oncology Studies (40 papers) and Prostate Cancer Treatment and Research (29 papers). Mark A. Preston is often cited by papers focused on Bladder and Urothelial Cancer Treatments (60 papers), Urinary and Genital Oncology Studies (40 papers) and Prostate Cancer Treatment and Research (29 papers). Mark A. Preston collaborates with scholars based in United States, Germany and Canada. Mark A. Preston's co-authors include Quoc‐Dien Trinh, Adam S. Kibel, Toni K. Choueiri, Mani Menon, Joaquim Bellmunt, Steven L. Chang, Maxine Sun, Jeffrey J. Leow, Thomas Seisen and Alexander P. Cole and has published in prestigious journals such as Journal of Clinical Oncology, Diabetes Care and JNCI Journal of the National Cancer Institute.

In The Last Decade

Mark A. Preston

117 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with ¹⁸ F-DCFPyL in Prostate Cancer Patients (OSPREY)

2021 244 citations Mark A. Preston et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark A. Preston United States	30	1.6k	1.1k	615	386	305	123	2.7k
Thomas J. Guzzo United States	34	1.6k 1.1×	1.6k 1.5×	594 1.0×	685 1.8×	240 0.8×	238	3.6k
Giuseppe Carrieri Italy	29	1.1k 0.7×	1.3k 1.2×	449 0.7×	402 1.0×	340 1.1×	178	2.9k
Michele Marchioni Italy	27	823 0.5×	1.4k 1.3×	425 0.7×	281 0.7×	207 0.7×	169	2.2k
Eu Chang Hwang South Korea	26	901 0.6×	1.3k 1.2×	648 1.1×	475 1.2×	263 0.9×	229	2.8k
Manish I. Patel Australia	31	846 0.5×	1.7k 1.5×	510 0.8×	610 1.6×	575 1.9×	151	3.2k
Florian Roghmann Germany	26	936 0.6×	804 0.7×	352 0.6×	351 0.9×	203 0.7×	115	1.9k
Dipen J. Parekh United States	35	1.7k 1.1×	1.8k 1.6×	462 0.8×	1.0k 2.6×	478 1.6×	192	3.9k
Wade J. Sexton United States	32	1.7k 1.1×	2.1k 1.9×	860 1.4×	466 1.2×	472 1.5×	194	4.2k
Hwang Gyun Jeon South Korea	32	1.1k 0.7×	1.9k 1.7×	411 0.7×	362 0.9×	360 1.2×	192	3.1k
Rodney H. Breau Canada	34	1.3k 0.9×	2.3k 2.1×	575 0.9×	505 1.3×	393 1.3×	237	4.2k

Countries citing papers authored by Mark A. Preston

Since Specialization

Citations

This map shows the geographic impact of Mark A. Preston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Preston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Preston more than expected).

Fields of papers citing papers by Mark A. Preston

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Preston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Preston. The network helps show where Mark A. Preston may publish in the future.

Co-authorship network of co-authors of Mark A. Preston

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Preston. A scholar is included among the top collaborators of Mark A. Preston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Preston. Mark A. Preston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Garje, Rohan, Bernadett Szabados, Colleen Peyton, et al.. (2025). LBA112 Neoadjuvant gemcitabine intravesical system (TAR-200) + cetrelimab (CET) or CET alone in patients (pts) with muscle-invasive bladder cancer (MIBC): SunRISe-4 (SR-4) primary analysis and biomarker results. Annals of Oncology. 36. S1652–S1653.

Carlsson, Sigrid, Mark A. Preston, Andrew J. Vickers, et al.. (2024). A Provider-Facing Decision Support Tool for Prostate Cancer Screening in Primary Care: A Pilot Study. Applied Clinical Informatics. 15(2). 274–281. 1 indexed citations

Yim, Kendrick, Benjamin V. Stone, Matthew Mossanen, et al.. (2024). Contemporary Perioperative Outcomes of Open Retroperitoneal Lymph Node Dissection for Testicular Cancer. JU Open Plus. 2(3).

Skelton, William Paul, Jonathan Thomas, Rohit Jain, et al.. (2024). Impact of Angiotensin Converting Enzyme Inhibitors on Pathologic Complete Response With Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer. Clinical Genitourinary Cancer. 22(5). 102143–102143.

Yim, Kendrick, Christopher J. Magnani, Adam S. Feldman, et al.. (2023). Anticoagulation prophylaxis patterns following retroperitoneal lymph node dissection for testis cancer. Urologic Oncology Seminars and Original Investigations. 41(12). 489.e1–489.e6. 1 indexed citations

Melnick, Kevin, Kendrick Yim, Timothy N. Clinton, et al.. (2023). Evidence-Based Analysis of the Critical Steps of Radical Cystectomy for Bladder Cancer. Journal of Clinical Medicine. 12(21). 6845–6845. 2 indexed citations

Wang, Ye, Matthew Mossanen, Mark A. Preston, et al.. (2021). Robotic-assisted radical cystectomy is associated with lower perioperative mortality in octogenarians. Urologic Oncology Seminars and Original Investigations. 40(4). 163.e19–163.e23. 6 indexed citations

Gild, Philipp, David‐Dan Nguyen, Sean A. Fletcher, et al.. (2019). Contemporary Survival Rates for Muscle-Invasive Bladder Cancer Treated With Definitive or Non-Definitive Therapy. Clinical Genitourinary Cancer. 17(3). e488–e493. 12 indexed citations

Nassar, Amin H., Renato Umeton, Jaegil Kim, et al.. (2018). Mutational Analysis of 472 Urothelial Carcinoma Across Grades and Anatomic Sites. Clinical Cancer Research. 25(8). 2458–2470. 87 indexed citations

10.

Fletcher, Sean A., Marieke J. Krimphove, Alexander P. Cole, et al.. (2018). Characterizing trends in treatment modalities for localized muscle-invasive bladder cancer in the pre-immunotherapy era. World Journal of Urology. 36(11). 1767–1774. 11 indexed citations

11.

Hanna, Nawar, Quoc‐Dien Trinh, Thomas Seisen, et al.. (2018). Effectiveness of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer in the Current Real World Setting in the USA. European Urology Oncology. 1(1). 83–90. 51 indexed citations

12.

McKay, Rana R., Bruce Montgomery, Wanling Xie, et al.. (2017). Post prostatectomy outcomes of patients with high-risk prostate cancer treated with neoadjuvant androgen blockade. Prostate Cancer and Prostatic Diseases. 21(3). 364–372. 41 indexed citations

13.

Vetterlein, Malte W., Thomas Seisen, Jeffrey J. Leow, et al.. (2017). Effect of Nonurothelial Histologic Variants on the Outcomes of Radical Cystectomy for Nonmetastatic Muscle-invasive Urinary Bladder Cancer. Clinical Genitourinary Cancer. 16(1). e129–e139. 15 indexed citations

14.

Downer, Mary K., Christopher B. Allard, Mark A. Preston, et al.. (2017). Regular Aspirin Use and the Risk of Lethal Prostate Cancer in the Physicians’ Health Study. European Urology. 72(5). 821–827. 49 indexed citations

15.

Mossanen, Matthew, et al.. (2017). Approach to the Patient with High-Risk Prostate Cancer. Urologic Clinics of North America. 44(4). 635–645. 6 indexed citations

16.

Preston, Mark A., Julie L. Batista, Kathryn M. Wilson, et al.. (2016). Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer. Journal of Clinical Oncology. 34(23). 2705–2711. 77 indexed citations

17.

Roghmann, Florian, Praful Ravi, Julian Hanske, et al.. (2015). Perioperative outcomes after radical cystectomy at NCI-designated centres: Are they any better?. Canadian Urological Association Journal. 9(5-6). 207–207. 9 indexed citations

18.

Sánchez, Alejandro, Dayron Rodríguez, Christopher B. Allard, et al.. (2015). Primary genitourinary melanoma: Epidemiology and disease-specific survival in a large population-based cohort. Urologic Oncology Seminars and Original Investigations. 34(4). 166.e7–166.e14. 46 indexed citations

19.

Preston, Mark A., Adam S. Feldman, John J. Coen, et al.. (2015). Active surveillance for low-risk prostate cancer: Need for intervention and survival at 10 years. Urologic Oncology Seminars and Original Investigations. 33(9). 383.e9–383.e16. 22 indexed citations

20.

Preston, Mark A., et al.. (2009). Leveraging the Cloud for Green IT: Predicting the Energy, Cost and Performance of Cloud Computing.. Int. CMG Conference. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact